← Back to Clinical Trials
Recruiting NCT06139354

NCT06139354 Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06139354
Status Recruiting
Phase
Sponsor University of Arkansas
Condition Hiv
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-10-04
Primary Completion 2026-06

Trial Parameters

Condition Hiv
Sponsor University of Arkansas
Study Type INTERVENTIONAL
Phase N/A
Enrollment 45
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-10-04
Completion 2026-06
Interventions
decision aid

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this trial is to pilot a digital, interactive patient-provider HIV PEP decision aid. The decision aid will incorporate five sections of content: 1) key clinical factors input by providers; 2) tailored multimedia-based HIV risk sharing information; 3) standardized multimedia educational messaging regarding the effectiveness, risks, and benefits of HIV PEP; 4) direct comparisons of priorities (e.g., physical well-being - "I want to do everything I can to prevent HIV," privacy - "I don't want others to know about the exposure," or cost - "I can't afford the pills'') completed by patients; and 5) tailored feedback regarding patient priorities for use in shared clinical decision making.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * seeking care from DCFNE following sexual assault * able to provide consent and participate in the study in English * meets CDC criteria for HIV PEP \[a) seeking care within 72 hours of potential exposure, b) potential exposure\] Exclusion Criteria: * \<18 years old * Does not meet CDC criteria for HIV PEP \[seeking care \>72 hours after assault, assault with minimal/low exposure risk\] * unable to complete study requirements in English

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology